(NASDAQ: YARW) Yarrow Bioscience's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.8%.
Yarrow Bioscience's earnings in 2026 is -$18,709,000.On average, 4 Wall Street analysts forecast YARW's earnings for 2026 to be -$124,583,697, with the lowest YARW earnings forecast at -$143,899,309, and the highest YARW earnings forecast at -$102,318,015. On average, 3 Wall Street analysts forecast YARW's earnings for 2027 to be -$4,493,183, with the lowest YARW earnings forecast at -$4,316,979, and the highest YARW earnings forecast at -$4,625,335.
In 2028, YARW is forecast to generate -$6,671,695 in earnings, with the lowest earnings forecast at -$6,410,060 and the highest earnings forecast at -$6,867,922.